| Title: | Interaction between genetic predisposition, smoking, and dementia risk: a population-based cohort study |
| Journal: | Scientific Reports |
| Published: | 21 Jun 2021 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/34155245/ |
| DOI: | https://doi.org/10.1038/s41598-021-92304-x |
| URL: | https://www.nature.com/articles/s41598-021-92304-x.pdf |
| Citations: | 8 (4 in last 2 years) as of 8 Aug 2024 |
Publication 5259
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
We evaluated whether the association between cigarette smoking and dementia risk is modified by genetic predisposition including apolipoprotein E (APOE) genotype and polygenic risk (excluding the APOE region). We included 193,198 UK Biobank participants aged 60-73 years without dementia at baseline. Of non-APOE-ε4 carriers, 0.89% (95% CI 0.73-1.08%) current smokers developed dementia compared with 0.49% (95% CI 0.44-0.55%) of never smokers (adjusted HR 1.78; 95% CI 1.39-2.29). In contrast, of one APOE-ε4 allele carriers, 1.69% (95% CI 1.31-2.12%) current smokers developed dementia compared with 1.40% (95% CI 1.25-1.55%) of never smokers (adjusted HR 1.06; 95% CI 0.77-1.45); of two APOE-ε4 alleles carriers, 4.90% (95% CI 2.92-7.61%) current smokers developed dementia compared with 3.87% (95% CI 3.11-4.74%) of never smokers (adjusted HR 0.94; 95% CI 0.49-1.79). Of participants with high polygenic risk, 1.77% (95% CI 1.35-2.27%) current smokers developed dementia compared with 1.05% (95% CI 0.91-1.21%) of never smokers (adjusted HR 1.63; 95% CI 1.16-2.28). A significant interaction was found between APOE genotype and smoking status (P = 0.002) while no significant interaction was identified between polygenic risk and smoking status (P = 0.25). APOE genotype but not polygenic risk modified the effect of smoking on dementia risk.</p>
9 Authors
- Na Zhang
- Janice M. Ranson
- Zhi-Jie Zheng
- Eilis Hannon
- Zhenwei Zhou
- Xuejun Kong
- David J. Llewellyn
- Daniel A. King
- Jie Huang
Enabling scientific discoveries that improve human health